Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Hadoux, Julien;Lamarca, Angela;Grande, Enrique;Deandreis, Désirée;ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org;et.al.
(2024) ESMO Open — Vol. 9, n° 10, p. 103664 [1-18] (2024)

Files

2024_Hadoux_ESMO_Open.pdf
  • Open Access
  • Adobe PDF
  • 1.18 MB
  • https://creativecommons.org/licenses/by-nc-nd/4.0/

Details

Authors
  • Hadoux, Julien
    Author
  • Lamarca, Angela
    Author
  • Grande, Enrique
    Author
  • Deandreis, Désirée
    Author
  • Author
  • ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
    Collaborator
Show more
Abstract
• This Clinical Practice Guideline provides key recommendations for managing rare endocrine tumours. • Neuroendocrine neoplasms of different origins, parathyroid carcinoma and intrathyroid thymic neoplasms are included. • The guideline covers clinical imaging and pathological diagnosis, staging and risk assessment, treatment and follow-up. • The authors comprise a multidisciplinary group of experts from different institutions and countries in Europe. • Recommendations are based on available scientific data and the authors’ collective expert opinion.
Affiliations

Citations

Hadoux, J., Lamarca, A., Grande, E., Deandreis, D., Kaltsas, G., Janson, E. T., Tombal, B., Pavel, M., Thariat, J., van Velthuysen, M. F., Herman, P., Dromain, C., Baudin, E., & Berruti, A. (2024). Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open, 9(10), 103664 [1-18]. https://doi.org/10.1016/j.esmoop.2024.103664 (Original work published 2024)